Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06024109
What this trial is testing

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Who this might be right for
Abnormal Uterine BleedingEndometriosisUterine Prolapse+5 more
Aesculap AG 132
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Looking for participantsNCT04575935
What this trial is testing

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Who this might be right for
Advanced Ovarian CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Tumor+22 more
M.D. Anderson Cancer Center 580
Not applicableNot Yet RecruitingNCT07031908
What this trial is testing

Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Testing effectiveness (Phase 2)Looking for participantsNCT07432633
What this trial is testing

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Looking for participantsNCT06268665
What this trial is testing

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Who this might be right for
Breast CancerBreast Cancer Stage IBreast Cancer Stage II+34 more
University of California, Davis 86
Not applicableUnknownNCT02408536
What this trial is testing

Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

Who this might be right for
Low-grade Serous Ovarian CarcinomaRecurrent Invasive Borderline Serous Ovarian Cancer
National Cancer Institute, Naples 150
Testing effectiveness (Phase 2)Study completedNCT03947151
What this trial is testing

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

Who this might be right for
Invasive Ductal Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 8
Testing effectiveness (Phase 2)Ended earlyNCT05012397
What this trial is testing

Milademetan in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more
Rain Oncology Inc 40
Not applicableLooking for participantsNCT05059444
What this trial is testing

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Who this might be right for
Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+14 more
Guardant Health, Inc. 2,285
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT07318051
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study

Who this might be right for
Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more
Natera, Inc. 9,600
Not applicableUnknownNCT04402333
What this trial is testing

Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival

Who this might be right for
Ovarian CancerOvarian NeoplasmOvarian Neoplasm Epithelial+2 more
Royal Surrey County Hospital NHS Foundation Trust 40
Early research (Phase 1)Study completedNCT01308944
What this trial is testing

Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients

Who this might be right for
Invasive Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Washington University School of Medicine 24
Not applicableTemporarily pausedNCT03987555
What this trial is testing

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Who this might be right for
Solid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more
Wake Forest University Health Sciences 55
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Not applicableUnknownNCT05801276
What this trial is testing

CtDNA Methylation for Detecting Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerCirculating Tumor DNADNA Methylation+6 more
Lei Li 1,400
Not applicableLooking for participantsNCT06709872
What this trial is testing

A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline From Stage I Invasive Ovarian Cancer

Who this might be right for
Stage I Ovarian CancerBorderline Ovarian Tumors
KU Leuven 400
Next Page